Published in Nature on November 09, 1973
The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes. J Exp Med (1976) 2.32
Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts. J Exp Med (1974) 1.69
Further evidence for the role of macrophages in the initiation of lymphocyte trapping. Immunology (1974) 1.09
The Mouse Genome Database (MGD): from genes to mice--a community resource for mouse biology. Nucleic Acids Res (2005) 8.19
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A (2001) 6.99
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc Natl Acad Sci U S A (2001) 4.62
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell (1990) 3.98
Clonal origin bladder cancer. N Engl J Med (1992) 3.97
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
Combinatorial chemoprevention of intestinal neoplasia. Nat Med (2000) 3.66
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
The distribution of 51Cr-labeled lymphocytes into antigen-stimulated mice. Lymphocyte trapping. J Exp Med (1971) 2.60
Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet (1983) 2.30
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer (2001) 2.26
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med (1997) 2.12
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int (2000) 2.03
Nutritional support in hospitals in the United Kingdom: national survey 1988. Health Trends (1990) 2.03
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature (1970) 1.95
Cell proliferation in human basal cell carcinoma. Cancer Res (1970) 1.93
Short term benefits of post-operative oral dietary supplements in surgical patients. Clin Nutr (1992) 1.87
Abnormal cell proliferation in psoriasis. J Invest Dermatol (1968) 1.85
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
Pitfalls and practice of Luria-Delbrück fluctuation analysis: a review. Cancer Res (1988) 1.69
The distribution of chromium 51-labelled lymphoid cells in the mouse. A survey of anatomical compartments. Cell Immunol (1970) 1.67
Antigenicity in mice of antilymphocyte gamma-globulin. Nature (1967) 1.67
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol (1994) 1.64
Relation between osmolality of diet and gastrointestinal side effects in enteral nutrition. Br Med J (Clin Res Ed) (1984) 1.63
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut (1983) 1.60
The ichthyosiform dermatoses. II. Autoradiographic studies of epidermal proliferation. J Invest Dermatol (1966) 1.54
Ichthyosiform dermatoses. Classification based on anatomic and biometric observations. Arch Dermatol (1966) 1.52
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity. Arthritis Rheum (1975) 1.46
Gastric emptying in the critically ill--the way forward? Intensive Care Med (1997) 1.45
Should we warn against night shifts to prevent breast cancer? Occup Environ Med (2010) 1.44
Risk factors in the onset of neck/shoulder pain in a prospective study of workers in industrial and service companies. Occup Environ Med (2003) 1.42
Periodontal disease. Etiology and pathogenesis. Vet Clin North Am Small Anim Pract (1986) 1.40
Survival of skin heterografts under treatment with antilymphocytic serum. Lancet (1968) 1.39
Exercises versus arthroscopic decompression in patients with subacromial impingement: a randomised, controlled study in 90 cases with a one year follow up. Ann Rheum Dis (2005) 1.39
Kinetics of human epidermal cell proliferation: diurnal variation. J Invest Dermatol (1968) 1.38
The use of subcellular fractions to raise anti-lymphocytic serum. Immunology (1968) 1.36
Quantitative studies on tissue transplantation immunity. IX. Induction of tolerance with antilymphocytic serum. Proc R Soc Lond B Biol Sci (1969) 1.33
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol (1996) 1.29
The cellular origin of the lymphochte trap. Immunology (1974) 1.27
Topical administration of Vitamin A acid for ichthyosiform dermatoses and psoriasis. JAMA (1969) 1.24
Fabry's disease. Its ocular manifestations. Arch Ophthalmol (1965) 1.24
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Homing of specifically sensitized lymphocytes to allografts of skin. Cell Immunol (1972) 1.20
The roles of lactose and Clostridium difficile in the pathogenesis of enteral feeding associated diarrhoea. Clin Nutr (1983) 1.19
Physical exposure assessment in monotonous repetitive work--the PRIM study. Scand J Work Environ Health (2001) 1.19
Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo. Arch Dermatol (1970) 1.19
The mechanism of action of anti-lymphocyte serum. Studies of antibody eluate. J Exp Med (1969) 1.13
Eye changes in ichthyosis. JAMA (1968) 1.11
Further evidence for the role of macrophages in the initiation of lymphocyte trapping. Immunology (1974) 1.09
The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells. Nature (1974) 1.08
Limb and joint transplantation. A review of research and clinical experience. Clin Orthop Relat Res (1974) 1.07
INHIBITION OF IODIDE OXIDATION BY THYROXINE AND OTHER ANTIOXIDANTS. Proc Natl Acad Sci U S A (1959) 1.07
The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice. Int J Cancer (1990) 1.07
Location of proliferating cells in human epidermis. Arch Dermatol (1970) 1.07
Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. Cancer Res (1991) 1.07
A comparative study of marine salmonid alphavirus subtypes 1-6 using an experimental cohabitation challenge model. J Fish Dis (2011) 1.06
Antigenic change and cell maturation in murine thymocytes. Cell Immunol (1970) 1.06
Induction of tolerance with antilymphocytic serum. Transplant Proc (1969) 1.06
Selective suppression of cellular immunity by antilymphocyte serum. Transplantation (1968) 1.06
The radiolabeling of lymphocytes and tumor cells with 111indium. Proc Soc Exp Biol Med (1978) 1.06
Immunosuppressive effects of heterologous antilymphocyte serum in monkeys. Lancet (1970) 1.04
Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res (1983) 1.04
Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier. Transplant Proc (1971) 1.03
The effect of histocompatibility antigens on lymphocyte migration in the mouse. Immunology (1972) 1.02
Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol (1971) 1.01
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
The effects of ALG on the murine immune response to sheep erythrocytes. Immunology (1972) 1.01
The biology of unknown primary tumors. Semin Oncol (1993) 1.01
Foetal antigens and cancer. Nature (1973) 1.00
Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group. JAMA (1991) 1.00
A functional and morphologic study of intracranial thyroid allografts in the dog. Surg Gynecol Obstet (1967) 0.99
Phototoxic potential of minocycline and doxycycline. Arch Dermatol (1972) 0.99
A serological method for detecting the surface antigens of epidermal cells. Transplantation (1971) 0.99
Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays. J Natl Cancer Inst (1978) 0.99
Cell proliferation kinetics in benign and malignant skin diseases in humans. Natl Cancer Inst Monogr (1969) 0.98
Methacycline and demeclocycline in relation to sunlight. JAMA (1971) 0.98
Effects of Indoleacetic Acid and Other Oxidation Regulators on in Vitro Peroxidation and Experimental Conversion of Eugenol to Lignin. Plant Physiol (1960) 0.98
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. Clin Exp Immunol (1975) 0.98
Immunoregulation by spleen-seeking thymocytes. II. Role in the response to sheep erythrocytes. Cell Immunol (1974) 0.97
Fabry's disease--glycolipid lipidosis. Histochemical and electron microscopic studies of two cases. Am J Med (1966) 0.96
Feto-placental adaptations to maternal obesity in the baboon. Placenta (2009) 0.96
Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Occup Environ Med (2005) 0.96
A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int (2001) 0.96
Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. Cancer Res (1988) 0.95
On a possible epigenetic mechanism(s) of tumor cell heterogeneity. The role of DNA methylation. Cancer Metastasis Rev (1983) 0.95
Localized epidermolytic hyperkeratosis. A form of keratoderma of the palms and soles. Arch Dermatol (1970) 0.95
Lymphocyte trapping in tolerant mice. Nat New Biol (1971) 0.94
Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine. J Exp Med (1984) 0.94
Study of lymphoid cells from inflamed synovial membranes. Ann Rheum Dis (1975) 0.93
Understanding work related musculoskeletal pain: does repetitive work cause stress symptoms? Occup Environ Med (2005) 0.93
Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants. Cancer Metastasis Rev (1982) 0.93